Open Access

New guidelines: Importance to reduce LDL-C in patients at risk.

Congress Session

About the speaker

Professor Luis Masana

University Hospital Sant Joan de Reus, Reus (Spain)
0 follower

4 more presentations in this session

Welcome and introduction.

Speaker: Professor J. Chapman (Paris, FR) Professor L. Tokgozoglu (Ankara, TR)

Thumbnail

The role of add-on therapies in the management of high and very high CV risk patients.

Speaker: Professor P. Perrone-Filardi (Naples, IT)

Thumbnail

Novel options for the combination of LDL-C lowering therapies.

Speaker: Professor K. Ray (London, GB)

Thumbnail

Live Q & A with chairmen & speakers.

Speaker: Professor L. Tokgozoglu (Ankara, TR) Professor J. Chapman (Paris, FR)

Thumbnail

Access the full session

Add on to take back control: Combining lipid lowering therapies for the management of high risk patients

Speakers: Professor L. Masana, Professor J. Chapman, Professor L. Tokgozoglu, Professor P. Perrone-Filardi, Professor K. Ray...
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

Open Access

Putting into practice: A challenging ASCVD case study.

29 August 2021

Open Access

Panel Discussion: The case for combination therapy: The way forward in intensive LDL-c management?

27 August 2021

Open Access

LDL-c in the management of high CV risk: Changing the paradigm for prevention.

27 August 2021

This platform is supported by

logo Novo Nordisk